Shilpa Pharma Secures CEP Certification for Nifedipine API
Shilpa Pharma Lifesciences Secures CEP for Nifedipine API from EDQM Shilpa Pharma Lifesciences Limited, a wholly-owned subsidiary of Shilpa Medicare Limited, has been granted a Certificate of Suitability (CEP) by the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its Active Pharmaceutical Ingredient (API), Nifedipine. A CEP certifies that the API complies…